Biomx Inc
PHGE0.393USD
-0.010-2.46%
收盘 11/10, 16:00（美东）报价延迟15分钟
10.39M总市值
亏损市盈率 TTM
关于 Biomx Inc 公司
BiomX Inc.（前身为 Chardan Healthcare Acquisition Corp.）是一家微生物组公司。该公司专注于开发天然和人工噬菌体疗法。它开发的疗法旨在靶向和消灭影响皮肤外观的细菌以及慢性疾病中的有害细菌，例如炎症性肠病 (IBD)、原发性硬化性胆管炎 (PSC) 和癌症。该公司发现并验证细菌靶标，并针对这些靶标定制噬菌体组合物。其产品线包括 BX001、BX002 和 BX003。BX001 是一种可改善易长痤疮皮肤外观的候选产品。BX002 是一种定制的噬菌体混合物，可消除与 IBD 发病相关的细菌靶标。BX003 是一种针对肺炎克雷伯菌 (Kp) 特定菌株开发的定制噬菌体混合物。
Biomx Inc简介
公司代码PHGE
公司名称Biomx Inc
上市日期Dec 18, 2018
CEOMr. Jonathan Eitan Solomon
员工数量52
证券类型Ordinary Share
年结日Dec 18
公司地址22 Einstein St.
城市NESS-ZIONA
上市交易所NYSE American Consolidated
国家Israel
邮编7414003
电话972723942377
网址https://www.biomx.com/
公司代码PHGE
上市日期Dec 18, 2018
CEOMr. Jonathan Eitan Solomon
Biomx Inc公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Jonathan Eitan Solomon
Mr. Jonathan Eitan Solomon
Chief Executive Officer, Director
Chief Executive Officer, Director
179.80K
--
Dr. Merav Bassan, Ph.D.
Dr. Merav Bassan, Ph.D.
Chief Development Officer
Chief Development Officer
111.35K
--
Ms. Marina Wolfson, CPA
Ms. Marina Wolfson, CPA
Chief Financial Officer
Chief Financial Officer
68.92K
--
Ms. Susan Blum, CPA
Ms. Susan Blum, CPA
Independent Director
Independent Director
--
--
Mr. Jonathan S. Leff
Mr. Jonathan S. Leff
Independent Director
Independent Director
--
--
Dr. Alan Charles Moses, M.D.
Dr. Alan Charles Moses, M.D.
Independent Director
Independent Director
--
--
Dr. Jesse Goodman, M.D.
Dr. Jesse Goodman, M.D.
Independent Director
Independent Director
--
--
Dr. Russell G. Greig, Ph.D.
Dr. Russell G. Greig, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Eddie Williams
Mr. Eddie Williams
Independent Director
Independent Director
--
--
Mr. Gregory Merril
Mr. Gregory Merril
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Jonathan Eitan Solomon
Mr. Jonathan Eitan Solomon
Chief Executive Officer, Director
Chief Executive Officer, Director
179.80K
--
Dr. Merav Bassan, Ph.D.
Dr. Merav Bassan, Ph.D.
Chief Development Officer
Chief Development Officer
111.35K
--
Ms. Marina Wolfson, CPA
Ms. Marina Wolfson, CPA
Chief Financial Officer
Chief Financial Officer
68.92K
--
Ms. Susan Blum, CPA
Ms. Susan Blum, CPA
Independent Director
Independent Director
--
--
Mr. Jonathan S. Leff
Mr. Jonathan S. Leff
Independent Director
Independent Director
--
--
Dr. Alan Charles Moses, M.D.
Dr. Alan Charles Moses, M.D.
Independent Director
Independent Director
--
--
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 11月7日 周五
更新时间: 11月7日 周五
持股股东
股东类型
持股股东
持股股东
占比
Deerfield Management Company, L.P.
9.39%
Cystic Fibrosis Foundation
9.39%
Nantahala Capital Management, LLC
9.39%
Morgan Stanley & Co. LLC
6.98%
Centaurus Investments Limited
4.03%
其他
60.81%
持股股东
持股股东
占比
Deerfield Management Company, L.P.
9.39%
Cystic Fibrosis Foundation
9.39%
Nantahala Capital Management, LLC
9.39%
Morgan Stanley & Co. LLC
6.98%
Centaurus Investments Limited
4.03%
其他
60.81%
股东类型
持股股东
占比
Hedge Fund
24.92%
Corporation
13.42%
Research Firm
8.61%
Holding Company
4.03%
Venture Capital
3.76%
Investment Advisor/Hedge Fund
2.34%
Individual Investor
1.46%
Investment Advisor
0.09%
其他
41.37%
机构持股
更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
38
10.55M
39.72%
-5.15M
2025Q2
48
19.36M
73.97%
+6.20M
2025Q1
47
17.95M
68.92%
+5.32M
2024Q4
47
13.90M
76.65%
+2.77M
2024Q3
43
13.00M
74.85%
+8.58M
2024Q2
33
4.45M
66.70%
+1.05M
2024Q1
34
2.97M
56.90%
+586.97K
2023Q4
35
2.25M
51.72%
+502.58K
2023Q3
39
1.91M
46.61%
-56.19K
2023Q2
39
1.94M
47.21%
+273.60K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Deerfield Management Company, L.P.
2.49M
9.39%
--
--
Jun 30, 2025
Cystic Fibrosis Foundation
2.49M
9.39%
+706.35K
+39.51%
Feb 27, 2025
Nantahala Capital Management, LLC
2.49M
9.39%
--
--
Jun 30, 2025
Morgan Stanley & Co. LLC
1.85M
6.98%
+1.85M
--
Jun 30, 2025
Centaurus Investments Limited
1.07M
4.03%
+1.07M
--
Apr 21, 2025
Ikarian Capital LLC
892.98K
3.36%
--
--
Jun 30, 2025
AMR Action Fund LP
876.89K
3.3%
+571.40K
+187.05%
Sep 30, 2024
Telmina Ltd
560.27K
2.11%
+276.30K
+97.30%
Sep 30, 2024
Nimble Ventures LLC
510.20K
1.92%
+1.00
+0.00%
Sep 30, 2024
J.P. Morgan Securities LLC
430.00K
1.62%
--
--
Jun 30, 2025
查看更多
持股ETF
机构名称
占比
暂无数据
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
Aug 15, 2024
Merger
10→1
Aug 15, 2024
Merger
10→1
Aug 15, 2024
Merger
10→1
Aug 15, 2024
Merger
10→1
公告日期
类型
比率
Aug 15, 2024
Merger
10→1
Aug 15, 2024
Merger
10→1
Aug 15, 2024
Merger
10→1
Aug 15, 2024
Merger
10→1
